Authors
Loading...
Review explores mechanisms of action and enhancement strategies for rituximab in B-cell lymphoma, highlighting pathways to improve clinical efficacy.
Cartron et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: